Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
David Mulherin Innovates Patient Safety at VUMC with Tech
Research & Development David Mulherin Innovates Patient Safety at VUMC with Tech

In the ever-evolving landscape of healthcare, where technology and patient care intersect, few individuals stand out as prominently as David Mulherin, a clinical informatics pharmacist and lead application analyst at Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. His

How Is Telehealth Transforming Flu Care in Garland, Texas?
Tech & Innovation How Is Telehealth Transforming Flu Care in Garland, Texas?

In the heart of Garland, Texas, a quiet revolution in healthcare is unfolding as flu season looms on the horizon, bringing with it the usual challenges of packed waiting rooms and strained medical facilities, but now, local families are finding relief through a groundbreaking telehealth program.

AI Boosts Detection of Hidden Airway Blockages in Study
Tech & Innovation AI Boosts Detection of Hidden Airway Blockages in Study

Imagine a scenario where a patient struggles to breathe, plagued by persistent coughing and choking, yet standard medical imaging fails to reveal the cause—a foreign object silently lodged in their airway, posing a life-threatening risk. Such cases of foreign body aspiration (FBA), particularly

How Did Telehealth Transform Psychosocial Oncology in COVID-19?
Tech & Innovation How Did Telehealth Transform Psychosocial Oncology in COVID-19?

When the COVID-19 pandemic swept across the globe, it brought healthcare systems to a critical juncture, particularly in the realm of psychosocial oncology, which addresses the emotional, psychological, and social challenges faced by cancer patients. Overnight, the risk of infection made

Breaking Retraction Fibers Boosts Migrasome Harvesting Efficiency
Biotech & Bioprocessing Breaking Retraction Fibers Boosts Migrasome Harvesting Efficiency

In the rapidly evolving field of cellular biology, a groundbreaking advancement has emerged that promises to reshape the study of migrasomes, a unique type of organelle critical to cell communication and various physiological processes. These organelles, formed by migrating cells, play essential

CONNECT TarGeT: Revolutionizing Childhood Brain Cancer Care
Research & Development CONNECT TarGeT: Revolutionizing Childhood Brain Cancer Care

In a world where childhood brain cancer remains one of the most heartbreaking diagnoses a family can face, a groundbreaking initiative is lighting the way toward hope and healing with remarkable determination. The CONNECT TarGeT clinical trial, a transatlantic research effort, is targeting some of

Mapping Resistance Mutations in Acinetobacter Baumannii
Tech & Innovation Mapping Resistance Mutations in Acinetobacter Baumannii

In hospital wards across the United States, a silent threat looms large, with over 1% of patients battling infections caused by Acinetobacter baumannii , a bacterium notorious for its ability to resist multiple antibiotics. This pathogen, often linked to severe outcomes like prolonged hospital

How Do Australian Clinical Networks Use Evidence for Safety?
Research & Development How Do Australian Clinical Networks Use Evidence for Safety?

In the intricate landscape of Australia’s healthcare system, where public and private sectors intersect, clinical networks stand as vital pillars in the pursuit of patient safety and quality care, ensuring that evidence-based practices are seamlessly integrated. These collaborative groups, made up

Genetic Feedback Boosts Engineered Cell Protein Output
Biotech & Bioprocessing Genetic Feedback Boosts Engineered Cell Protein Output

In the rapidly evolving field of synthetic biology, a groundbreaking study from the University of Warwick has unveiled a transformative approach to enhance the productivity of engineered microbial cell factories, as detailed in a recent publication in Nature Communications . These microscopic

MIT Unveils New Vaccine Targets to Fight Tuberculosis
Research & Development MIT Unveils New Vaccine Targets to Fight Tuberculosis

What happens when a disease, hidden in plain sight, claims over a million lives each year, yet remains stubbornly resistant to modern medicine? Tuberculosis (TB), caused by Mycobacterium tuberculosis , stands as one of humanity's oldest and deadliest foes, striking hardest in vulnerable communities

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later